YOKNEAM, ISRAEL and CINCINNATI, OH -- (MARKET WIRE) -- February 27, 2007 -- Syneron Medical Ltd. (NASDAQ: ELOS) and The Procter & Gamble Company (NYSE: PG) (P&G) announced today they signed an exclusive joint development and supply agreement for the commercialization of patented, elos™ based, home-use devices and compositions for the enhancement of skin appearance through the treatment of fine lines, wrinkles, age and sun spots and cellulite.
